Biotechnology products signify a major advancement in our world today. Products resulting from biotechnology will revolutionize how health care is delivered. One of these technologic breakthroughs is recombinant human erythropoietin (epoetin).1 Its impact on the delivery of care to the anemic renal patient is changing the roles of nurses who provide care for these patients. Epoetin alfa has virtually eliminated the necessity of transfusions in the renal patient population, while simultaneously improving the quality of life for those patients and their families. To appropriately monitor the patient receiving epoetin therapy, the nurse must understand iron physiology and metabolism, factors that influence blood pressure, and factors that can blunt the response to epoetin therapy, and still appreciate the individual nursing requirements of each patient. Such juggling of information demands that the critical care nurse be alert to the subtle changes occurring within the patient, thereby allowing sound decisions based on astute nursing assessment
Skip Nav Destination
Article navigation
1 August 1992
Renal Replacement|
August 01 1992
Erythropoietin Use in the Critical Care Setting
Lowanna S. Binkley, MA, RN, CNN;
*From Amgen Inc., Thousand Oaks, California, Nebraska.
Reprint requests to Lowanna S. Binkley, MA, RN, CNN, 77 W. Avenida de las Flores, Thousand Oaks, CA 91360.
Search for other works by this author on:
Ali Whittaker, MS, RN
Ali Whittaker, MS, RN
†From Creighton University, School of Nursing, Mary Lanning Campus, Hastings, Nebraska.
Search for other works by this author on:
AACN Adv Crit Care (1992) 3 (3): 640–649.
Citation
Lowanna S. Binkley, Ali Whittaker; Erythropoietin Use in the Critical Care Setting. AACN Adv Crit Care 1 August 1992; 3 (3): 640–649. doi: https://doi.org/10.4037/15597768-1992-3010
Download citation file:
Sign in
Don't already have an account? Register
Short-term Access
Purchase short-term access on a pay-per-article or pay-per-issue basis.
$15 72 - hour single article access $30 7 - day full issue access
0
Views